https://www.technologytimesnewjersey.com/article/910292917-luke-guinee-expands-into-consulting-services-for-business-and-cybersecurity-strategy Technology Times New Jersey en PressRelease 2026-05-05T12:00:00+00:00 Luke Guinee Expands Into Consulting Services for Business and Cybersecurity Strategy https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847129-luke-guinee-photo-196x258.jpeg https://www.technologytimesnewjersey.com/article/910497087-kura-oncology-to-report-first-quarter-2026-financial-results Technology Times New Jersey en PressRelease 2026-05-05T11:30:00+00:00 Kura Oncology to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.technologytimesnewjersey.com/article/910497096-intellia-therapeutics-to-participate-in-upcoming-investor-conferences Technology Times New Jersey en PressRelease 2026-05-05T11:30:00+00:00 Intellia Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.technologytimesnewjersey.com/article/910497160-bridgebio-to-present-primary-results-from-the-phase-3-calibrate-trial-at-2026-ece Technology Times New Jersey en PressRelease 2026-05-05T11:30:00+00:00 BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.technologytimesnewjersey.com/article/910497278-tris-pharma-appoints-jim-potenziano-ph-d-as-chief-science-and-development-officer Technology Times New Jersey en PressRelease 2026-05-05T11:30:00+00:00 Tris Pharma Appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer https://ml.globenewswire.com/media/2ab6667c-5742-4090-afb8-459cd811c92e/small/logo-png.png https://www.technologytimesnewjersey.com/article/910497370-rumble-announces-receipt-of-all-regulatory-approvals-for-business-combination-with-northern-data Technology Times New Jersey en PressRelease 2026-05-05T11:30:00+00:00 Rumble Announces Receipt of all Regulatory Approvals for Business Combination with Northern Data https://ml.globenewswire.com/media/e41a1c60-94cb-441c-8c8e-c8202cad5bce/small/image1-png.png https://www.technologytimesnewjersey.com/article/910497407-cytokinetics-announces-positive-topline-results-from-acacia-hcm-the-pivotal-phase-3-clinical-trial-of-aficamten-in-patients-with-non-obstructive Technology Times New Jersey en PressRelease 2026-05-05T11:30:00+00:00 Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy https://ml.globenewswire.com/media/adcf634e-a2a7-4cdf-98b3-ca658eab1b35/medium/figure-1-assessments-of-kccq-and-pvo2.png https://www.technologytimesnewjersey.com/article/910497410-earthdaily-selected-by-national-reconnaissance-office-nro-for-commercial-optical-earth-observation-contract Technology Times New Jersey en PressRelease 2026-05-05T11:30:00+00:00 EarthDaily Selected by National Reconnaissance Office (NRO) for Commercial Optical Earth Observation Contract https://ml.globenewswire.com/media/ec2bd8c0-33c6-4f6f-b3ea-93ebb0fc6a7b/small/eda-logo-main-png.png https://www.technologytimesnewjersey.com/article/910497459-joveo-introduces-ai-scheduling-automating-interview-coordination-for-candidates-and-recruiting-teams Technology Times New Jersey en PressRelease 2026-05-05T11:30:00+00:00 Joveo Introduces AI Scheduling, Automating Interview Coordination for Candidates and Recruiting Teams https://ml.globenewswire.com/media/5471b275-666e-434d-b3ca-d0de793a6030/small/joveo-logo-with-padding-png.png https://www.technologytimesnewjersey.com/article/910497479-nuvectis-pharma-inc-reports-first-quarter-2026-financial-results-and-business-highlights Technology Times New Jersey en PressRelease 2026-05-05T11:30:00+00:00 Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/aceda01c-bc94-4579-88fa-c0294406b49f/small/nuvectispharma-logos-final-full-color-png.png https://www.technologytimesnewjersey.com/article/910497109-sarah-campbell-joins-future-technologies-venture-llc-as-chief-operating-officer Technology Times New Jersey en PressRelease 2026-05-05T11:15:00+00:00 Sarah Campbell Joins Future Technologies Venture LLC as Chief Operating Officer https://ml.globenewswire.com/media/1e5769f5-e08b-4f6e-a31a-c16f2fd74179/medium/sarah-campbell.png https://www.technologytimesnewjersey.com/article/910497392-cellectar-biosciences-reports-positive-12-month-follow-up-data-from-phase-2b-clover-wam-study-demonstrating-durable-responses-and-efficacy-of Technology Times New Jersey en PressRelease 2026-05-05T11:10:00+00:00 Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://www.technologytimesnewjersey.com/article/910497403-uniqure-announces-first-quarter-2026-financial-results-and-provides-recent-company-updates Technology Times New Jersey en PressRelease 2026-05-05T11:05:00+00:00 uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates https://ml.globenewswire.com/media/2ba61fe2-12e5-4a01-afe1-419652b31512/small/logo-uniqure-ms-word-orange-jpg.jpg https://www.technologytimesnewjersey.com/article/910497148-invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Technology Times New Jersey en PressRelease 2026-05-05T11:01:00+00:00 Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png https://www.technologytimesnewjersey.com/article/910497078-biocryst-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.technologytimesnewjersey.com/article/910497083-dupixent-dupilumab-demonstrates-improved-esophageal-function-in-eosinophilic-esophagitis-eoe-phase-4-trial Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910497093-kymera-therapeutics-presents-new-preclinical-ibd-data-for-kt-579-a-first-in-class-oral-irf5-degrader-at-digestive-disease-week Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://www.technologytimesnewjersey.com/article/910497100-factset-increases-dividend Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 FactSet Increases Dividend https://ml.globenewswire.com/media/4a408b1d-1e84-4d5c-ad1d-e7a396bcca9d/small/factset-research-systems-inc.jpg https://www.technologytimesnewjersey.com/article/910497116-orvida-pharma-to-present-functional-endpoint-development-data-in-rare-palmoplantar-skin-disorders-at-the-83rd-annual-meeting-of-the-society-for Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Orvida Pharma to Present Functional Endpoint Development Data in Rare Palmoplantar Skin Disorders at the 83rd Annual Meeting of the Society for Investigative Dermatology and the 2026 Epidermal Differentiation Disorders Symposium https://ml.globenewswire.com/media/cd4d7fc1-6bca-4b1d-a6b3-2314ed21fb79/small/orvida-final-46-jpg.jpg https://www.technologytimesnewjersey.com/article/910497194-editas-medicine-announces-first-quarter-2026-results-and-business-updates Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Editas Medicine Announces First Quarter 2026 Results and Business Updates https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://www.technologytimesnewjersey.com/article/910497200-climb-bio-hosts-budoprutug-r-d-spotlight-event-highlighting-topline-subcutaneous-formulation-data-broad-b-cell-mediated-disease-opportunity-and Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://www.technologytimesnewjersey.com/article/910497206-arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026 Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026 https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg https://www.technologytimesnewjersey.com/article/910497215-relmada-therapeutics-to-present-ndv-01-abstracts-at-aua2026 Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026 https://ml.globenewswire.com/media/8a986b0a-11c8-4551-b0ad-ec20fe2fe40a/small/relmada-logo-png.png https://www.technologytimesnewjersey.com/article/910497220-electra-therapeutics-announces-first-patient-dosed-in-phase-1-study-of-ipsoprubart-ela026-in-t-cell-malignancies Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies https://ml.globenewswire.com/media/5c28c3ad-0aec-4979-b6c4-12f1d4bf4c46/small/electra-logo-rgb-png.png https://www.technologytimesnewjersey.com/article/910497226-brewdog-announces-partnership-with-underbelly-as-official-beer-supplier-of-underbelly-at-the-edinburgh-fringe Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 BrewDog Announces Partnership with Underbelly as Official Beer Supplier of Underbelly at the Edinburgh Fringe https://ml.globenewswire.com/media/dc1f57dc-8a83-444e-8722-08f858c451af/medium/brewdog-underbelly.jpeg https://www.technologytimesnewjersey.com/article/910497236-repligen-reports-first-quarter-2026-financial-results-and-updates-full-year-2026-financial-guidance Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://www.technologytimesnewjersey.com/article/910497247-atea-pharmaceuticals-to-host-first-quarter-2026-financial-results-and-business-update-conference-call-on-may-12-2026 Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Atea Pharmaceuticals to Host First Quarter 2026 Financial Results and Business Update Conference Call on May 12, 2026 https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png https://www.technologytimesnewjersey.com/article/910497251-shoals-technologies-group-inc-reports-financial-results-for-first-quarter-2026 Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Shoals Technologies Group, Inc. Reports Financial Results for First Quarter 2026 https://ml.globenewswire.com/media/ed989abb-a0ae-4d05-9ca2-5a77f42cd208/small/shoals-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910497290-seres-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-updates Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.technologytimesnewjersey.com/article/910497311-eupraxia-pharmaceuticals-reports-erefs-data-from-its-ongoing-phase-1b-2a-resolve-trial-in-eosinophilic-esophagitis-at-digestive-disease-week-ddw Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW) https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.technologytimesnewjersey.com/article/910497313-ocular-therapeutix-reports-first-quarter-2026-financial-results-and-business-highlights Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910497336-rhythm-pharmaceuticals-reports-first-quarter-2026-financial-results-and-business-update Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.technologytimesnewjersey.com/article/910497362-nrx-pharmaceuticals-nasdaq-nrxp-announces-initiation-of-commercial-manufacturing-for-preservative-free-ketamine Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.technologytimesnewjersey.com/article/910497398-shopify-delivers-again-as-merchants-clear-100-billion-in-q1-gmv Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Shopify Delivers Again as Merchants Clear $100 Billion in Q1 GMV https://ml.globenewswire.com/media/28cdf29b-fa48-43e3-a710-ea3ab811a26c/small/shopify-logo-black-png.png https://www.technologytimesnewjersey.com/article/910497412-cellectar-biosciences-announces-oversubscribed-financing-up-to-140-million Technology Times New Jersey en PressRelease 2026-05-05T11:00:00+00:00 Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://www.technologytimesnewjersey.com/article/910487809-biontech-ver-ffentlicht-ergebnisse-f-r-das-erste-quartal-2026-sowie-informationen-zur-gesch-ftsentwicklung Technology Times New Jersey en PressRelease 2026-05-05T10:45:00+00:00 BioNTech veröffentlicht Ergebnisse für das erste Quartal 2026 sowie Informationen zur Geschäftsentwicklung https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/ https://www.technologytimesnewjersey.com/article/910487854-biontech-announces-first-quarter-2026-financial-results-and-corporate-update Technology Times New Jersey en PressRelease 2026-05-05T10:45:00+00:00 BioNTech Announces First Quarter 2026 Financial Results and Corporate Update https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/190705-biontech-logo-rgb-dark-green-preferred-0-png.png https://www.technologytimesnewjersey.com/article/910488011-netcoins-partners-with-talos-to-power-institutional-grade-trading-capabilities Technology Times New Jersey en PressRelease 2026-05-05T10:00:00+00:00 Netcoins Partners with Talos to Power Institutional-Grade Trading Capabilities https://ml.globenewswire.com/media/89ef7b10-6e38-47e8-abde-094b50c79b92/small/screen-shot-2019-10-02-at-2-16-55-pm-png.png https://www.technologytimesnewjersey.com/article/910488123-fortrea-reports-first-quarter-2026-results Technology Times New Jersey en PressRelease 2026-05-05T10:00:00+00:00 Fortrea Reports First Quarter 2026 Results https://ml.globenewswire.com/media/9fbbe00b-8782-464e-83e6-5843c563884a/small/fortrea-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910488127-aclarion-announces-second-commercial-agreement-with-weill-cornell-medicine Technology Times New Jersey en PressRelease 2026-05-05T10:00:00+00:00 Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://www.technologytimesnewjersey.com/article/910487861-welche-internetl-sung-empfiehlt-sich-f-r-gesch-ftsreisen-darum-ist-holafly-for-business-die-erste-wahl-f-r-globale-unternehmen Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 Welche Internetlösung empfiehlt sich für Geschäftsreisen? Darum ist Holafly for Business die erste Wahl für globale Unternehmen https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910487885-quelle-est-la-meilleure-solution-internet-pour-les-voyages-d-affaires-pourquoi-holafly-for-business-s-impose-comme-le-choix-privil-gi-des Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 Quelle est la meilleure solution internet pour les voyages d’affaires ? Pourquoi Holafly for Business s’impose comme le choix privilégié des entreprises internationales https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910487898-cu-l-es-la-mejor-soluci-n-de-internet-para-viajes-de-negocios-por-qu-holafly-for-business-se-est-convirtiendo-en-la-opci-n-preferida-para-las Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 ¿Cuál es la mejor solución de Internet para viajes de negocios? Por qué Holafly for Business se está convirtiendo en la opción preferida para las empresas globales https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910487907-holafly-for-business Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 출장 시 가장 적합한 인터넷 솔루션은 무엇인가? Holafly for Business가 글로벌 기업들의 선호 선택지로 떠오르고 있는 이유 https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910487922-holafly Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 מהו פתרון האינטרנט הטוב ביותר לנסיעות עסקים? מדוע Holafly לעסקים הופך לבחירה המועדפת על חברות גלובליות https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910487926 Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 出張に最適なインターネットソリューションとは? オラフライ・フォー・ビジネスがグローバル企業に選ばれ始めている理由 https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910487929-qual-a-melhor-solu-o-de-internet-para-viagens-de-neg-cios-por-que-a-holafly-for-business-est-se-tornando-a-escolha-preferida-das-empresas-globais Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 Qual é a melhor solução de internet para viagens de negócios? Por que a Holafly for Business está se tornando a escolha preferida das empresas globais https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910487930-apakah-penyelesaian-internet-terbaik-untuk-perjalanan-perniagaan-mengapa-holafly-for-business-menjadi-pilihan-utama-bagi-syarikat-global Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 Apakah penyelesaian internet terbaik untuk perjalanan perniagaan? Mengapa Holafly for Business menjadi pilihan utama bagi syarikat global https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910487931-holafly-for-business Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 公幹途中，哪種互聯網方案最為理想？ 為何 Holafly for Business 正成為全球企業的首選方案 https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910487932-holafly-for-business Technology Times New Jersey en PressRelease 2026-05-05T09:53:05+00:00 商务出行的最佳网络解决方案是什么？ Holafly for Business 为何正成为全球企业首选 https://ml-eu.globenewswire.com/media/6fd52eaa-879b-4688-a7cd-d1a5d9103943/small/holafly-logo-png.png https://www.technologytimesnewjersey.com/article/910478657-no-deposit-bonus-canada-2026-free-spins-no-deposit-by-mybookie Technology Times New Jersey en PressRelease 2026-05-05T09:14:04+00:00 No Deposit Bonus Canada 2026 | Free Spins No Deposit By MyBookie https://ml.globenewswire.com/media/610dd1d9-8ed5-4a69-b667-da4fef64484d/medium/mybookie.png https://www.technologytimesnewjersey.com/article/910458835-latest-findings-from-dme-aware-delphi-study-presented-at-arvo-2026-annual-meeting Technology Times New Jersey en PressRelease 2026-05-05T08:00:00+00:00 Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting https://ml-eu.globenewswire.com/media/dc25de9c-07c8-448a-b6af-aea02249e593/medium/global-consensus-on-early-intervention-in-dme.png https://www.technologytimesnewjersey.com/article/910458853-ecca-and-ttec-release-visionary-voices-research-on-the-future-of-contact-centre-sales-in-europe Technology Times New Jersey en PressRelease 2026-05-05T08:00:00+00:00 ECCA and TTEC Release “Visionary Voices” Research on the Future of Contact Centre Sales in Europe https://ml.globenewswire.com/media/8488146d-993c-40c8-8d4c-b993aa023cb2/small/screenshot-2025-10-17-132937-png.png https://www.technologytimesnewjersey.com/article/910458857-spec-releases-the-spec-cpu-2026-benchmark-suites-to-address-the-latest-advances-in-cpu-memory-and-compiler-technology Technology Times New Jersey en PressRelease 2026-05-05T08:00:00+00:00 SPEC Releases the SPEC CPU 2026 Benchmark Suites to Address the Latest Advances in CPU, Memory, and Compiler Technology https://ml.globenewswire.com/media/f6b299a2-9328-4f49-a915-406713f6443f/medium/cpu.jpeg https://www.technologytimesnewjersey.com/article/910458841-virtune-ab-publ-virtune-has-completed-the-monthly-rebalancing-for-april-2026-of-its-virtune-crypto-top-10-index-etp-the-first-crypto-index-etp Technology Times New Jersey en PressRelease 2026-05-05T07:56:11+00:00 Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for April 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/logo-png.png https://www.technologytimesnewjersey.com/article/910458908-virtune-ab-publ-virtune-har-genomf-rt-den-m-natliga-rebalanseringen-f-r-april-2026-av-virtune-crypto-top-10-index-etp-nordens-f-rsta Technology Times New Jersey en PressRelease 2026-05-05T07:56:11+00:00 Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för april 2026 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/ https://www.technologytimesnewjersey.com/article/910448866-newhydrogen-drives-toward-commercial-success Technology Times New Jersey en PressRelease 2026-05-05T07:01:00+00:00 NewHydrogen Drives Toward Commercial Success https://ml.globenewswire.com/media/a8022b5b-f0f7-416d-baf4-953e4db35884/small/newhydrogen-logo-png.png https://www.technologytimesnewjersey.com/article/910448817-cytospire-therapeutics-announces-oversubscribed-61-million-83m-series-a-financing-to-advance-pipeline-of-first-in-class-pan-gamma-delta-t-cell Technology Times New Jersey en PressRelease 2026-05-05T07:00:00+00:00 Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer https://ml-eu.globenewswire.com/media/99e8d7e3-84e7-41a5-84aa-4f03dcb8e2be/medium/natalie-mount.jpg https://www.technologytimesnewjersey.com/article/910448852-gauth-expands-across-southeast-asia-with-rollout-of-live-tutor-ai-learning-feature Technology Times New Jersey en PressRelease 2026-05-05T07:00:00+00:00 Gauth Expands Across Southeast Asia With Rollout of Live Tutor AI Learning Feature https://ml.globenewswire.com/media/24dc62df-03f6-45e4-96e2-5f67d96b35c9/medium/gauth-live-tutor.jpeg https://www.technologytimesnewjersey.com/article/910448853-gauth-berekspansi-ke-asia-tenggara-melalui-peluncuran-fitur-belajar-dengan-live-tutor-berteknologi-ai Technology Times New Jersey en PressRelease 2026-05-05T07:00:00+00:00 Gauth Berekspansi ke Asia Tenggara Melalui Peluncuran Fitur Belajar dengan Live Tutor Berteknologi AI https://ml.globenewswire.com/Resource/Download/9c01f10f-a4fd-41a7-81bc-8aa8d4b93ef1/image4.jpeg https://www.technologytimesnewjersey.com/article/910448859-gauth-meluaskan-kehadiran-di-asia-tenggara-melalui-pelancaran-ciri-pembelajaran-ai-live-tutor Technology Times New Jersey en PressRelease 2026-05-05T07:00:00+00:00 GAUTH Meluaskan Kehadiran di Asia Tenggara Melalui Pelancaran Ciri Pembelajaran AI Live Tutor https://ml.globenewswire.com/Resource/Download/32502339-11e9-420b-af9e-5645afb77262/image4.jpeg https://www.technologytimesnewjersey.com/article/910448861-gauth-live-tutor-ai Technology Times New Jersey en PressRelease 2026-05-05T07:00:00+00:00 Gauth ขยายธุรกิจทั่วเอเชียตะวันออกเฉียงใต้ เปิดตัวฟีเจอร์ Live Tutor การเรียนรู้ที่ใช้ AI https://ml.globenewswire.com/Resource/Download/2e119eae-5bcc-4f9b-882f-ea97c6d89a2b/image4.jpeg https://www.technologytimesnewjersey.com/article/910448864-gauth-m-r-ng-t-i-ng-nam-v-i-vi-c-tri-n-khai-t-nh-n-ng-h-c-t-p-ai-live-tutor Technology Times New Jersey en PressRelease 2026-05-05T07:00:00+00:00 Gauth Mở Rộng Tại Đông Nam Á Với Việc Triển Khai Tính Năng Học Tập AI Live Tutor https://ml.globenewswire.com/Resource/Download/05d732ea-2b15-444a-82bc-3bbd2b1c4729/image4.jpeg https://www.technologytimesnewjersey.com/article/910448874-sparc-ai-hires-senergy-communication-capital Technology Times New Jersey en PressRelease 2026-05-05T06:49:11+00:00 SPARC AI Hires Senergy Communication Capital https://ml.globenewswire.com/media/63c144a0-5c1d-45ef-99bc-e677d522fbb0/small/sparc-ai-logo-png.png https://www.technologytimesnewjersey.com/article/910448845-novonesis-delivered-strong-start-to-the-year-with-7-organic-sales-growth-in-q1 Technology Times New Jersey en PressRelease 2026-05-05T06:18:16+00:00 Novonesis delivered strong start to the year with 7% organic sales growth in Q1 https://ml-eu.globenewswire.com/media/d0c3bcb0-65ab-400f-9219-15fbf4253148/small/novonesis-logo-1-png.png https://www.technologytimesnewjersey.com/article/910439198-abivax-announces-repurchase-of-royalty-certificates-and-pricing-of-45m-38-5m-offering-of-american-depositary-shares Technology Times New Jersey en PressRelease 2026-05-05T06:00:00+00:00 Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png https://www.technologytimesnewjersey.com/article/910439216-kinetic-deploys-fiber-optic-network-for-a-more-reliable-digital-future Technology Times New Jersey en PressRelease 2026-05-05T05:21:08+00:00 Kinetic Deploys Fiber-Optic Network for a More Reliable Digital Future https://ml.globenewswire.com/media/YTk3YjM5OTktMmNkNC00OWFjLWE1OGYtZTJiZWYxMmQ3NjIyLTUwMDE2MjEyNC0yMDI2LTA1LTA1LWVu/tiny/Kinetic.png https://www.technologytimesnewjersey.com/article/910429701-santhera-ver-ffentlicht-einladung-zur-ordentlichen-generalversammlung Technology Times New Jersey en PressRelease 2026-05-05T05:00:00+00:00 Santhera veröffentlicht Einladung zur ordentlichen Generalversammlung https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.technologytimesnewjersey.com/article/910429709-santhera-publishes-agenda-for-its-annual-general-meeting Technology Times New Jersey en PressRelease 2026-05-05T05:00:00+00:00 Santhera Publishes Agenda for its Annual General Meeting https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://www.technologytimesnewjersey.com/article/910273837-qry-s-april-benchmarks-show-paid-media-ctr-up-42-as-awareness-cpms-hit-low Technology Times New Jersey en PressRelease 2026-05-04T15:59:06+00:00 QRY's April Benchmarks Show Paid Media CTR Up 42% as Awareness CPMs Hit Low https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847023-qry-paid-media-benchmarks-2400x1256.png https://www.technologytimesnewjersey.com/article/910410583-gauth-launches-live-tutor-in-vietnam-expanding-access-to-personalized-ai-learning-support Technology Times New Jersey en PressRelease 2026-05-05T03:00:00+00:00 Gauth Launches Live Tutor in Vietnam, Expanding Access to Personalized AI Learning Support https://ml.globenewswire.com/media/e59917c4-2978-4e18-b33e-f4d600b4a967/medium/gauth-live-tutor.jpeg https://www.technologytimesnewjersey.com/article/910410585-gauth-ra-m-t-t-nh-n-ng-live-tutor-t-i-vi-t-nam-m-r-ng-kh-n-ng-ti-p-c-n-h-tr-h-c-t-p-ai-c-nh-n-h-a Technology Times New Jersey en PressRelease 2026-05-05T03:00:00+00:00 Gauth Ra Mắt Tính Năng Live Tutor Tại Việt Nam, Mở Rộng Khả Năng Tiếp Cận Hỗ Trợ Học Tập AI Cá Nhân Hóa https://ml.globenewswire.com/Resource/Download/6fee188f-4308-4720-ab4f-43ee512b0463/image3.jpeg https://www.technologytimesnewjersey.com/article/910361222-axiant-launches-with-innovative-process-first-methodology-to-address-automation-failures Technology Times New Jersey en PressRelease 2026-05-04T22:42:00+00:00 Axiant Launches with Innovative Process-First Methodology to Address Automation Failures https://pressranger.s3.us-west-1.amazonaws.com/3251527/axiant-logo.png https://www.technologytimesnewjersey.com/article/910342560-nanobiotix-announces-protocol-amendment-to-ongoing-global-phase-3-head-and-neck-cancer-study Technology Times New Jersey en PressRelease 2026-05-04T21:29:27+00:00 Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910342587-nanobiotix-annonce-un-amendement-du-protocole-de-l-tude-mondiale-de-phase-3-sur-le-cancer-de-la-t-te-et-du-cou Technology Times New Jersey en PressRelease 2026-05-04T21:29:27+00:00 NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910342532-edgesource-corporation-acquires-lyteworx-automation-systems-deepening-its-defense-and-intelligence-mission-capabilities Technology Times New Jersey en PressRelease 2026-05-04T21:28:35+00:00 Edgesource Corporation Acquires Lyteworx Automation Systems, Deepening Its Defense and Intelligence Mission Capabilities https://ml.globenewswire.com/media/ba7fdda5-6ced-4314-801e-44f9e00da542/small/edgesource-logo-pr-1200-png.png https://www.technologytimesnewjersey.com/article/910342447-jiade-limited-announces-pricing-of-up-to-12-0-million-registered-direct-offering Technology Times New Jersey en PressRelease 2026-05-04T21:10:00+00:00 JIADE LIMITED Announces Pricing of up to $12.0 Million Registered Direct Offering https://ml.globenewswire.com/media/66c132ba-862c-42c5-92fc-aab67a82bf74/small/logo-png.png https://www.technologytimesnewjersey.com/article/910342356-new-publication-demonstrates-tlx250-px-zircaix-potential-in-diagnosing-kidney-cancers-beyond-ccrcc Technology Times New Jersey en PressRelease 2026-05-04T21:00:00+00:00 New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.technologytimesnewjersey.com/article/910333422-tango-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Technology Times New Jersey en PressRelease 2026-05-04T20:31:00+00:00 Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png https://www.technologytimesnewjersey.com/article/910333352-teva-to-present-at-the-bofa-securities-health-care-conference Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 Teva to Present at the BofA Securities Health Care Conference https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.technologytimesnewjersey.com/article/910333368-vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://www.technologytimesnewjersey.com/article/910333377-cellectis-to-report-first-quarter-financial-results-on-may-11-2026 Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 Cellectis to Report First Quarter Financial Results on May 11, 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.technologytimesnewjersey.com/article/910333384-cellectis-publiera-ses-r-sultats-financiers-du-premier-trimestre-le-11-mai-2026 Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.technologytimesnewjersey.com/article/910333396-crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910333425-microvast-schedules-first-quarter-earnings-call Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 Microvast Schedules First Quarter Earnings Call https://ml.globenewswire.com/media/df776795-0f3f-47ee-8207-63d8c61b98bb/small/microvast-tag-bluewhite-png.png https://www.technologytimesnewjersey.com/article/910333429-opus-genetics-announces-fda-acceptance-of-opgx-lca5-into-rare-disease-evidence-principles-rdep-program Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://www.technologytimesnewjersey.com/article/910333432-eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026 Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://www.technologytimesnewjersey.com/article/910333456-bioage-to-host-r-d-day-focused-on-nlrp3-inhibition-on-may-8-2026 Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026 https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://www.technologytimesnewjersey.com/article/910333491-cvrx-announces-first-patient-enrollment-in-benefit-hf-a-landmark-heart-failure-trial-evaluating-barostim-in-significantly-expanded-population Technology Times New Jersey en PressRelease 2026-05-04T20:30:00+00:00 CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://www.technologytimesnewjersey.com/article/910333399-anaptys-to-participate-at-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference Technology Times New Jersey en PressRelease 2026-05-04T20:15:00+00:00 Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://www.technologytimesnewjersey.com/article/910333489-kuvi-integrates-with-kucoin-broker-pro-to-advance-agentic-finance-adoption Technology Times New Jersey en PressRelease 2026-05-04T20:15:00+00:00 Kuvi Integrates with KuCoin Broker Pro to Advance Agentic Finance Adoption https://ml.globenewswire.com/media/eff106d2-82fe-40b8-a438-742d86074e01/small/555-png.png https://www.technologytimesnewjersey.com/article/910324529-3-e-network-technology-signs-1-3m-convertible-note-agreement-with-institutional-investor Technology Times New Jersey en PressRelease 2026-05-04T20:10:00+00:00 3 E Network Technology Signs 1.3M Convertible Note Agreement with Institutional Investor https://ml.globenewswire.com/media/8f4e21c2-5e2c-4ce6-88ee-66c06500e891/small/22222-2026-01-14-183954-150-jpg.jpg https://www.technologytimesnewjersey.com/article/910324540-kyntra-bio-to-report-first-quarter-2026-financial-results Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 Kyntra Bio to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9105c1e9-d9e3-4b68-9fc8-261fed7db250/small/kyntra-bio-r-rgb-png.png https://www.technologytimesnewjersey.com/article/910324550-tactile-systems-technology-inc-reports-first-quarter-2026-financial-results Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7ecb6926-a715-4305-979c-a80795dbab83/small/tactile-medical-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910324583-rumble-announces-timing-of-first-quarter-2026-earnings-release-and-conference-call Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 Rumble Announces Timing of First Quarter 2026 Earnings Release and Conference Call https://ml.globenewswire.com/media/e41a1c60-94cb-441c-8c8e-c8202cad5bce/small/image1-png.png https://www.technologytimesnewjersey.com/article/910324622-clip-money-inc-announces-amendment-of-unsecured-convertible-notes Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 Clip Money Inc. Announces Amendment of Unsecured Convertible Notes https://ml.globenewswire.com/media/80569958-6412-49bc-802d-e98810b40181/small/logo-800-300dpi-png.png https://www.technologytimesnewjersey.com/article/910324625-everquote-announces-first-quarter-2026-financial-results Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 EverQuote Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/86005bfc-f760-4c2f-9bfc-d896152a9bea/small/everquote-jpg.jpg https://www.technologytimesnewjersey.com/article/910324647-silvaco-announces-participation-at-upcoming-investor-conferences Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 Silvaco Announces Participation at Upcoming Investor Conferences https://ml.globenewswire.com/media/86c898ba-7d91-45b3-9db0-edb7315ddaba/small/silvaco-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910324650-capricor-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-recent-corporate-update-on-may-12 Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12 https://ml.globenewswire.com/media/16ce4387-5b8f-447c-96b8-7c453633f9bf/small/getimage-48-768x274-png.png https://www.technologytimesnewjersey.com/article/910324654-lexicon-pharmaceuticals-announces-100-million-loan-facility-with-hercules-capital Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910324720-aktis-oncology-initiates-phase-1b-clinical-trial-for-aky-2519-a-b7-h3-miniprotein-radioconjugate-in-metastatic-castration-resistant-prostate-cancer Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC) https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.technologytimesnewjersey.com/article/910324766-oric-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-updates Technology Times New Jersey en PressRelease 2026-05-04T20:05:00+00:00 ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png https://www.technologytimesnewjersey.com/article/910324758-ocugen-announces-private-offering-of-115-million-of-convertible-senior-notes Technology Times New Jersey en PressRelease 2026-05-04T20:01:51+00:00 Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://www.technologytimesnewjersey.com/article/910324495-praxis-precision-medicines-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026-and-participate-in-upcoming-investor-conference Technology Times New Jersey en PressRelease 2026-05-04T20:01:00+00:00 Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.technologytimesnewjersey.com/article/910324509-fibrobiologics-reports-preclinical-data-showing-fibroblast-spheroids-may-actively-reprogram-the-burn-wound-environment-to-drive-healing-and-reduce Technology Times New Jersey en PressRelease 2026-05-04T20:01:00+00:00 FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.technologytimesnewjersey.com/article/910324510-biodesix-announces-first-quarter-2026-results-and-highlights Technology Times New Jersey en PressRelease 2026-05-04T20:01:00+00:00 Biodesix Announces First Quarter 2026 Results and Highlights https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png https://www.technologytimesnewjersey.com/article/910324629-hemab-therapeutics-announces-closing-of-upsized-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares Technology Times New Jersey en PressRelease 2026-05-04T20:01:00+00:00 Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/M2UyM2ExNWYtYTJjYi00M2RhLTkwZGEtNjZlYTUyMzI4NTI4LTEzMjE4MjEtMjAyNi0wNS0wNC1lbg==/tiny/Hemab-Therapeutics-Inc-.png https://www.technologytimesnewjersey.com/article/910324596-cytokinetics-to-announce-topline-results-from-acacia-hcm-the-pivotal-phase-3-clinical-trial-of-aficamten-in-patients-with-non-obstructive Technology Times New Jersey en PressRelease 2026-05-04T20:00:00+00:00 Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026 https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.technologytimesnewjersey.com/article/910324602-visionary-holdings-inc-announces-receipt-of-nasdaq-delisting-determination-letter-related-to-delinquent-listing-fees Technology Times New Jersey en PressRelease 2026-05-04T20:00:00+00:00 Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees https://ml.globenewswire.com/media/Mzc5NzU4NDctOGU1ZC00Y2JjLWE1YjEtMjkxMmYzYjM3M2Q3LTEzMTczMjYtMjAyNi0wNS0wNC1lbg==/tiny/Visionary-Holdings-Inc-.png https://www.technologytimesnewjersey.com/article/910324663-crn-recognizes-11-employees-at-climb-channel-solutions-on-the-2026-women-of-the-channel-list-and-names-climb-s-chief-marketing-officer-as-one-of-the Technology Times New Jersey en PressRelease 2026-05-04T19:29:34+00:00 CRN Recognizes 11 Employees at Climb Channel Solutions on the 2026 Women of the Channel List and Names Climb’s Chief Marketing Officer as one of the 2026 Women of the Channel Power 100 https://ml.globenewswire.com/media/c7f62397-551b-4c5f-ac67-cd3baeeb84e4/small/logo-png.png https://www.technologytimesnewjersey.com/article/910315198-roadzen-announces-pricing-of-8-million-registered-direct-offering-of-ordinary-shares Technology Times New Jersey en PressRelease 2026-05-04T19:27:19+00:00 Roadzen Announces Pricing of $8 Million Registered Direct Offering of Ordinary Shares https://ml.globenewswire.com/media/5101ee32-4aaf-4552-aa26-c4ed796caf72/small/roadzen-png.png https://www.technologytimesnewjersey.com/article/910315145-liabilityscore-announces-new-platform-to-bring-credit-score-logic-to-contract-risk-built-for-small-businesses-not-lawyers Technology Times New Jersey en PressRelease 2026-05-04T19:20:00+00:00 LiabilityScore Announces New Platform to Bring Credit-Score Logic to Contract Risk — Built for Small Businesses, Not Lawyers https://pressranger.s3.us-west-1.amazonaws.com/3240312/Commercial-Lease-Score.jpg https://www.technologytimesnewjersey.com/article/910306646-sana-commerce-appoints-brian-plackis-cheng-as-ceo Technology Times New Jersey en PressRelease 2026-05-04T18:20:25+00:00 Sana Commerce Appoints Brian Plackis Cheng as CEO https://ml-eu.globenewswire.com/media/ec9f9caa-d98f-47e3-acc7-b19eaab978ae/small/sana-logotype-red-rgb-png.png https://www.technologytimesnewjersey.com/article/910298991-michael-haske-to-become-isolved-ceo-as-company-embarks-on-next-phase-of-ai-led-growth Technology Times New Jersey en PressRelease 2026-05-04T18:00:00+00:00 Michael Haske to Become isolved CEO as Company Embarks on Next Phase of AI-Led Growth https://ml.globenewswire.com/media/c7803669-a575-4be5-a22a-b9982b790c1c/small/isolved-logo-color-pos-rgb-jpg.jpg https://www.technologytimesnewjersey.com/article/910298983-amazon-one-medical-glp-1-program-evaluated-how-the-new-program-works-what-it-costs-and-what-cash-pay-patients-should-know-first Technology Times New Jersey en PressRelease 2026-05-04T17:51:04+00:00 Amazon One Medical GLP-1 Program Evaluated: How the New Program Works, What It Costs, and What Cash-Pay Patients Should Know First https://ml.globenewswire.com/media/ee6fb8bf-1ad4-4b37-8ad6-34f3692f808e/medium/direct-meds.png https://www.technologytimesnewjersey.com/article/910291456-admaxxer-surpasses-5-000-active-brands-and-1-2-billion-in-tracked-gmv-reinforcing-its-position-as-a-leading-dtc-analytics-and-ai-ad-operations Technology Times New Jersey en PressRelease 2026-05-04T17:05:00+00:00 Admaxxer Surpasses 5,000 Active Brands and $1.2 Billion in Tracked GMV, Reinforcing Its Position as a Leading DTC Analytics and AI Ad Operations Platform https://pressranger.s3.us-west-1.amazonaws.com/3248977/Admaxxer-Surpasses-5%2C000-Active-Brands-and-%241.2-Billion-in-Tracked-GMV%2C-Reinforcing-Its-Position-as-a-Leading-DTC-Analytics-and-AI-Ad-Operations-Platform-Press.png https://www.technologytimesnewjersey.com/article/910291473-eascra-biotech-welcomes-dr-anne-yau-as-life-science-research-scientist Technology Times New Jersey en PressRelease 2026-05-04T17:04:04+00:00 Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist https://ml.globenewswire.com/media/1eda41c1-8c5d-43f0-9198-b0a1570f47e6/medium/dr-anne-yau.jpg https://www.technologytimesnewjersey.com/article/910278459-deepinfra-closes-107m-series-b-to-power-production-scale-ai-inference Technology Times New Jersey en PressRelease 2026-05-04T16:00:00+00:00 DeepInfra Closes $107M Series B to Power Production-Scale AI Inference https://ml.globenewswire.com/media/f36602ae-b2cf-4f29-be62-c811818f6e32/small/deepinfra-logo-horizontal-jpg.jpg https://www.technologytimesnewjersey.com/article/910278468-samba-tv-bolsters-technical-leadership-with-promotion-of-jaya-aswani-to-cto-and-appointment-of-ramzi-nasr-as-vp-of-engineering Technology Times New Jersey en PressRelease 2026-05-04T16:00:00+00:00 Samba TV bolsters technical leadership with promotion of Jaya Aswani to CTO and appointment of Ramzi Nasr as VP of Engineering https://ml.globenewswire.com/media/25a74fa7-09fe-4ed7-8189-1587683af145/small/samba-tv-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910278471-carahsoft-recognized-in-2025-broadcom-partner-awards Technology Times New Jersey en PressRelease 2026-05-04T16:00:00+00:00 Carahsoft Recognized in 2025 Broadcom Partner Awards https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png https://www.technologytimesnewjersey.com/article/910278515-asentum-announces-ase-token-presale-ahead-of-post-quantum-mainnet-release Technology Times New Jersey en PressRelease 2026-05-04T16:00:00+00:00 Asentum Announces $ASE Token Presale Ahead of Post-quantum Mainnet Release https://ml.globenewswire.com/media/ff6e601c-253e-46a5-aeb1-de722f4fdcd5/small/screenshot-2026-04-30-104146-png.png https://www.technologytimesnewjersey.com/article/910278486-microcloud-hologram-inc-efficient-deterministic-quantum-state-preparation-algorithm-based-on-decision-diagrams Technology Times New Jersey en PressRelease 2026-05-04T15:40:00+00:00 MicroCloud Hologram Inc. Efficient Deterministic Quantum State Preparation Algorithm Based on Decision Diagrams https://ml.globenewswire.com/media/OWYyYTNlYjctOWMzYi00ZmU4LWEyMTktOTQwOWU0MGM5Y2M1LTEzMTA4OTctMjAyNi0wNS0wNC1lbg==/tiny/MicroCloud-Hologram-Inc-.png https://www.technologytimesnewjersey.com/article/910278494-focus-school-software-celebrates-20-years-as-a-leading-national-provider-of-k-12-technology-solutions Technology Times New Jersey en PressRelease 2026-05-04T15:34:49+00:00 Focus School Software Celebrates 20 Years as a Leading National Provider of K-12 Technology Solutions https://ml.globenewswire.com/media/559730d4-2aa4-418f-81fa-507e7f90d91b/small/focus-logo-1200x630-jpg.jpg https://www.technologytimesnewjersey.com/article/910272579-warmysender-reaches-15-000-users-reinforcing-position-as-top-instantly-alternative Technology Times New Jersey en PressRelease 2026-05-04T15:15:00+00:00 WarmySender Reaches 15,000 Users, Reinforcing Position as Top Instantly Alternative https://pressranger.s3.us-west-1.amazonaws.com/3248932/WarmySender-Reaches-15%2C000-Users%2C-Reinforcing-Position-as-Top-Instantly-Alternative-Press.png https://www.technologytimesnewjersey.com/article/910272589-flyguys-launches-reality-behind-the-flight-a-new-podcast-exploring-the-world-of-reality-data-capture Technology Times New Jersey en PressRelease 2026-05-04T15:11:34+00:00 FlyGuys Launches “Reality: Behind the Flight,” A New Podcast Exploring the World of Reality Data Capture https://ml.globenewswire.com/media/MDIxMjMxODItNjljMi00ZmM3LTgyNDMtMzVlZmE5MWI0ODQxLTUwMDE2MjAxNy0yMDI2LTA1LTA0LWVu/tiny/FlyGuys-Inc-.png https://www.technologytimesnewjersey.com/article/910272515-intuitive-ai-achieves-aws-data-and-analytics-competency-as-enterprises-reassess-the-foundations-of-ai Technology Times New Jersey en PressRelease 2026-05-04T15:00:00+00:00 Intuitive.ai achieves AWS Data and Analytics Competency as Enterprises Reassess the Foundations of AI https://ml.globenewswire.com/media/3fc27a9a-561c-455c-b3a6-6a83ba8090b8/small/intuitive-logo-secondary-png.png https://www.technologytimesnewjersey.com/article/910272541-sophos-celebrates-22-leaders-named-to-2026-crn-women-of-the-channel-list Technology Times New Jersey en PressRelease 2026-05-04T14:56:39+00:00 Sophos Celebrates 22 Leaders Named to 2026 CRN Women of the Channel List https://ml.globenewswire.com/media/35db908a-b7b8-4ce0-b920-69875da346ba/small/sophos-1200x628-png.png https://www.technologytimesnewjersey.com/article/910266621-jama-software-launches-model-context-protocol-mcp-server Technology Times New Jersey en PressRelease 2026-05-04T14:45:00+00:00 Jama Software Launches Model Context Protocol (MCP) Server https://ml.globenewswire.com/media/0f19efa9-cf4d-43a0-9f83-4d48de067aec/small/jama-software-logo.png https://www.technologytimesnewjersey.com/article/910266571-flexera-channel-leaders-spotlighted-across-the-crn-2026-women-of-the-channel-list Technology Times New Jersey en PressRelease 2026-05-04T14:30:00+00:00 Flexera Channel Leaders Spotlighted Across the CRN® 2026 Women of the Channel List https://ml.globenewswire.com/media/691aa193-5f37-4e50-8fec-38e34f7a5e43/small/97e88b00-acec-4133-812f-8213dba8f99b-jpg.jpg https://www.technologytimesnewjersey.com/article/910262632-mmi-s-symani-surgical-system-treats-first-alzheimer-s-patient-in-groundbreaking-remind-study Technology Times New Jersey en PressRelease 2026-05-04T14:10:00+00:00 MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study https://ml.globenewswire.com/media/e9325bed-8fcb-4abf-b66e-6f076014b0fb/small/mmi-logo-stacked-tagline-positive-rgb1-png.png https://www.technologytimesnewjersey.com/article/910262667-owlting-group-nasdaq-owls-launches-owlpay-agent-wallet-targeting-the-emerging-multi-trillion-dollar-agentic-commerce-economy Technology Times New Jersey en PressRelease 2026-05-04T14:07:50+00:00 OwlTing Group (NASDAQ: OWLS) Launches OwlPay Agent Wallet, Targeting the Emerging Multi-Trillion-Dollar Agentic Commerce Economy https://ml.globenewswire.com/media/5a79481c-55d1-4e33-9f88-950aa88aeec5/medium/owlting-built-the-wallet-the-agentic-economy-needs-self-cust.jpg https://www.technologytimesnewjersey.com/article/910262611-research-on-new-class-of-treatments-for-ovarian-cancer-receives-725-000-in-funding-from-ovarian-cancer-canada-to-become-clinical-trial-ready Technology Times New Jersey en PressRelease 2026-05-04T14:00:00+00:00 Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready” https://ml.globenewswire.com/media/YWY2NGZiYWEtODcyZC00Y2I5LThkZGEtYmM5ZjlkYzFkNDMzLTEzMTI5NjUtMjAyNi0wNS0wNC1lbg==/tiny/Ovarian-Cancer-Canada.png https://www.technologytimesnewjersey.com/article/910262624-inqi-launches-ai-native-property-intelligence-platform-with-new-editor-and-expanded-iq-apps Technology Times New Jersey en PressRelease 2026-05-04T14:00:00+00:00 InQI Launches AI-Native Property Intelligence Platform with New Editor and Expanded IQ Apps https://pressranger.s3.us-west-1.amazonaws.com/3244005/inqi_image_2.png https://www.technologytimesnewjersey.com/article/910262626-spring-allergies-hit-lungs-hard-doctor-of-pharmacy-explains-what-actually-helps Technology Times New Jersey en PressRelease 2026-05-04T14:00:00+00:00 Spring Allergies Hit Lungs Hard: Doctor of Pharmacy Explains What Actually Helps https://ml.globenewswire.com/media/13a92186-d8d0-4494-9e0a-5fc1d2e363ee/small/betterbrand-logo-new-png.png https://www.technologytimesnewjersey.com/article/910258304-talkdesk-announces-new-integration-to-deliver-unified-healthcare-experience-and-outcomes-analytics Technology Times New Jersey en PressRelease 2026-05-04T13:32:15+00:00 Talkdesk announces new integration to deliver unified healthcare experience and outcomes analytics https://ml.globenewswire.com/media/b806fec8-0de9-496b-9ddc-7775b20acf14/small/talkdesk-logo-png.PNG https://www.technologytimesnewjersey.com/article/910258255-coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026 Technology Times New Jersey en PressRelease 2026-05-04T13:30:00+00:00 Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/07437af0-8ae3-48cf-952b-18bc6b99ca7c/small/coherus-onc-logo-rgb-150-png.png https://www.technologytimesnewjersey.com/article/910258274-intouch-insight-study-finds-mobile-ordering-success-hinges-on-reliability-not-speed Technology Times New Jersey en PressRelease 2026-05-04T13:30:00+00:00 Intouch Insight Study Finds Mobile Ordering Success Hinges on Reliability, Not Speed https://ml.globenewswire.com/media/MDhhNGZhN2MtZWVhZi00MWIwLTkxZDEtNmUyMjQ1ODIxMzM0LTUwMDE1NjYxNy0yMDI2LTA1LTA0LWVu/tiny/Intouch-Insight.png https://www.technologytimesnewjersey.com/article/910258286-alpha-tau-announces-100-local-disease-control-rate-and-favorable-safety-profile-observed-in-alpha-dart-pancreatic-cancer-trials-presented-at-ddw Technology Times New Jersey en PressRelease 2026-05-04T13:17:21+00:00 Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026 https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910258285-alternative-ballistics-corporation-otcqb-albc-to-host-corporate-update-call-on-may-7-2026-at-8-30-am-et Technology Times New Jersey en PressRelease 2026-05-04T13:15:00+00:00 Alternative Ballistics Corporation (OTCQB: ALBC) to Host Corporate Update Call on May 7, 2026 at 8:30 AM ET https://ml.globenewswire.com/media/6f3eddb5-8d1a-420e-b07f-3e21f440c666/small/albc-logo-png.png https://www.technologytimesnewjersey.com/article/910252863-prismatic-launches-skills-for-claude-code-to-help-developers-ship-integrations-faster Technology Times New Jersey en PressRelease 2026-05-04T13:05:00+00:00 Prismatic Launches Skills for Claude Code to Help Developers Ship Integrations Faster https://ml.globenewswire.com/media/3ffa5f28-f782-4562-9961-b68fe61d97c2/medium/prismatic-launches-skills-for-claude-code.png https://www.technologytimesnewjersey.com/article/910253033-greece-launches-world-s-first-national-wildfire-satellite-system-with-ororatech Technology Times New Jersey en PressRelease 2026-05-04T13:04:00+00:00 Greece Launches World’s First National Wildfire Satellite System with OroraTech https://ml.globenewswire.com/media/f405d4dd-2633-4e23-8086-bbaa6bf83b25/medium/ororatech-s-hellenic-fire-system.jpg https://www.technologytimesnewjersey.com/article/910253114-aura-biosciences-announces-pricing-of-260-million-public-offering-of-common-stock-and-pre-funded-warrants Technology Times New Jersey en PressRelease 2026-05-04T13:03:06+00:00 Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.technologytimesnewjersey.com/article/910252843-operant-ai-launches-endpoint-protector-securing-shadow-ai-coding-agents-and-mcp-across-the-enterprise Technology Times New Jersey en PressRelease 2026-05-04T13:00:00+00:00 Operant AI Launches Endpoint Protector: Securing Shadow AI, Coding Agents, and MCP Across the Enterprise https://ml.globenewswire.com/media/cf992a83-aa53-4fbe-8acd-1dbc5d0de200/small/operant-black-logo-master-png-png.png https://www.technologytimesnewjersey.com/article/910252851-asus-releases-2026-future-of-small-business-report Technology Times New Jersey en PressRelease 2026-05-04T13:00:00+00:00 ASUS Releases 2026 Future of Small Business Report https://pressranger.s3.us-west-1.amazonaws.com/3239907/Future-of-SMB-Report.png https://www.technologytimesnewjersey.com/article/910252862-carnosyn-brands-expands-tribsyn-applications-across-beverage-dairy-and-medical-nutrition Technology Times New Jersey en PressRelease 2026-05-04T13:00:00+00:00 CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition https://ml.globenewswire.com/media/4b40dd5b-0137-41f8-83de-422e4b4f3196/small/nai-full-logo-green2-0-png.png https://www.technologytimesnewjersey.com/article/910252869-oncolytics-biotech-reports-durable-responses-in-second-line-ras-mutant-mss-colorectal-cancer Technology Times New Jersey en PressRelease 2026-05-04T13:00:00+00:00 Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer https://ml.globenewswire.com/media/f0121259-b2be-4290-90a3-0d2c3b243aed/small/oncolytics-biotech-jpg.jpg https://www.technologytimesnewjersey.com/article/910252951-turtle-beach-corporation-restructures-credit-facilities-to-enhance-capital-return-flexibility Technology Times New Jersey en PressRelease 2026-05-04T13:00:00+00:00 Turtle Beach Corporation Restructures Credit Facilities to Enhance Capital Return Flexibility https://ml.globenewswire.com/media/f8a9689c-6753-486d-b902-84d519018cbe/small/turtlebeachcorp-logo-stacked-blk-28-11-2023-jpg.jpg https://www.technologytimesnewjersey.com/article/910252971-fate-therapeutics-announces-three-presentations-at-the-2026-asgct-annual-meeting-highlighting-off-the-shelf-car-t-cell-therapy-pipeline-for-cancer-and Technology Times New Jersey en PressRelease 2026-05-04T13:00:00+00:00 Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://www.technologytimesnewjersey.com/article/910253027-quantum-x-labs-files-u-s-patent-application-for-high-precision-quantum-atomic-clock-for-potential-use-in-the-aerospace-defense-industries Technology Times New Jersey en PressRelease 2026-05-04T12:52:00+00:00 Quantum X Labs Files U.S. Patent Application for High Precision Quantum Atomic Clock for Potential Use in the Aerospace & Defense Industries https://ml.globenewswire.com/media/a0abc50a-ff3e-420e-9e21-807bbc6417cd/small/logo-png.png https://www.technologytimesnewjersey.com/article/910253043-gyre-therapeutics-completes-acquisition-of-cullgen-to-create-u-s-and-china-based-fully-integrated-biopharmaceutical-company Technology Times New Jersey en PressRelease 2026-05-04T12:47:47+00:00 Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company https://ml.globenewswire.com/media/24951768-57e9-4d7a-b969-f00258b17136/small/gyre-logo-png.png https://www.technologytimesnewjersey.com/article/910253010-polyrizon-announces-u-s-patent-expansion-for-its-intranasal-drug-delivery-platform Technology Times New Jersey en PressRelease 2026-05-04T12:45:00+00:00 Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform https://ml.globenewswire.com/media/YWIxMzIzNDgtN2UwNy00NTAyLThjZDMtZWMwNGFjZTdmNWJhLTUwMDEyOTIyMy0yMDI2LTA1LTA0LWVu/tiny/Polyrizon-Ltd-.png https://www.technologytimesnewjersey.com/article/910252891-aitx-to-present-at-the-ld-micro-invitational-xvi Technology Times New Jersey en PressRelease 2026-05-04T12:40:00+00:00 AITX to Present at the LD Micro Invitational XVI https://ml.globenewswire.com/media/882a78f6-94c4-4a5c-a750-564a6dea2bb5/small/aitx-logo-1920x1080-2-png.png https://www.technologytimesnewjersey.com/article/910247553-mapi-pharma-explores-u-s-aseptic-manufacturing-facility-to-support-growing-demand-for-aseptic-and-long-acting-generic-and-innovative-injectables Technology Times New Jersey en PressRelease 2026-05-04T12:30:00+00:00 Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables https://ml.globenewswire.com/media/a15e698a-0f26-4d44-bf6a-78b7ae34d25d/small/mapi-pharma-logo-png.png https://www.technologytimesnewjersey.com/article/910247597-abeona-therapeutics-announces-date-of-first-quarter-financial-results Technology Times New Jersey en PressRelease 2026-05-04T12:30:00+00:00 Abeona Therapeutics® Announces Date of First Quarter Financial Results https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png https://www.technologytimesnewjersey.com/article/910247608-satellogic-expands-global-sales-force-with-senior-defense-and-intelligence-industry-veterans Technology Times New Jersey en PressRelease 2026-05-04T12:30:00+00:00 Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry Veterans https://ml.globenewswire.com/media/d2d0c386-2a99-4434-aa48-fc69a11ff8a7/small/satellogic-logo-png.png https://www.technologytimesnewjersey.com/article/910247610-fibrobiologics-announces-release-of-cywc628-drug-product-for-phase-1-2-diabetic-foot-ulcer-clinical-trial Technology Times New Jersey en PressRelease 2026-05-04T12:30:00+00:00 FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.technologytimesnewjersey.com/article/910247630-fortress-biotech-to-participate-in-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference Technology Times New Jersey en PressRelease 2026-05-04T12:30:00+00:00 Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference https://ml.globenewswire.com/media/d82bf2ce-81b7-4989-9e6b-08e6bb6e1f95/small/fortressbio1-jpg.jpg https://www.technologytimesnewjersey.com/article/910247641-service-robotics-growth-accelerates-as-global-demand-fuels-strategic-expansion Technology Times New Jersey en PressRelease 2026-05-04T12:30:00+00:00 Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion https://ml.globenewswire.com/media/45ff7033-6ad2-41ba-bbd1-912eb2907b3e/small/ainewswire-002-png.png https://www.technologytimesnewjersey.com/article/910247668-liquidia-corporation-to-report-first-quarter-2026-financial-results-on-may-11-2026 Technology Times New Jersey en PressRelease 2026-05-04T12:30:00+00:00 Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/f7659070-cc55-4e68-ae70-33013e7df72c/small/liquidia-new-logo-png.png https://www.technologytimesnewjersey.com/article/910247674-newgen-provides-update-on-fiscal-year-2025-results-and-strategic-progress Technology Times New Jersey en PressRelease 2026-05-04T12:30:00+00:00 NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress https://ml.globenewswire.com/media/ZWQwY2VjNmQtYTdlZi00YTUxLTg3NmItMmI3OWVkMTQ5MGQ4LTEyOTcwMTEtMjAyNi0wNS0wNC1lbg==/tiny/NewGenIvf-Limited.png https://www.technologytimesnewjersey.com/article/910247689-axe-compute-inc-nasdaq-agpu-ceo-chris-miglino-to-appear-on-schwab-network-may-4-and-cheddar-may-6 Technology Times New Jersey en PressRelease 2026-05-04T12:30:00+00:00 Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6 https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png https://www.technologytimesnewjersey.com/article/910242598-candel-therapeutics-to-host-investor-conference-call-following-presentation-of-extended-data-from-phase-3-trial-of-aglatimagene-besadenovec-in Technology Times New Jersey en PressRelease 2026-05-04T12:05:00+00:00 Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.technologytimesnewjersey.com/article/910242367-proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-2-2026 Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png https://www.technologytimesnewjersey.com/article/910242370-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial https://ml-eu.globenewswire.com/media/7cf77d4a-25b5-4471-a282-0334907cbfbd/small/falk-logo-rgb-jpg.jpg https://www.technologytimesnewjersey.com/article/910242372-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial https://ml-eu.globenewswire.com/media/540f0a78-db35-42ad-9e90-7b81e8ff3ad6/small/renirl-logo-png.png https://www.technologytimesnewjersey.com/article/910242373-cptx-to-present-preclinical-proof-of-principle-of-its-dna-based-in-vivo-car-t-platform-at-asgct-annual-meeting Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting https://ml-eu.globenewswire.com/media/b3ec9ca7-8866-466a-9d91-09342002e341/small/cptx-logo-high-res-png.png https://www.technologytimesnewjersey.com/article/910242419-evaxion-to-announce-business-update-and-first-quarter-2026-financial-results-on-may-7-2026 Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026 https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.technologytimesnewjersey.com/article/910242435-recludix-pharma-announces-upcoming-oral-presentations-on-preclinical-data-for-oral-stat6-inhibitor-rex-8756-and-topical-stat-1-3-inhibitors-at-the Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting https://ml.globenewswire.com/media/NDM5ZGUzYTItNGI0Zi00N2Y3LWE3Y2QtZmViNDYyN2I1ZWRjLTEyMzYyMjItMjAyNi0wNS0wNC1lbg==/tiny/Recludix-Pharma-Inc-.png https://www.technologytimesnewjersey.com/article/910242438-rhythm-pharmaceuticals-announces-new-data-presentations-in-acquired-hypothalamic-obesity-at-pediatric-endocrine-society Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.technologytimesnewjersey.com/article/910242442-spur-therapeutics-presents-clinical-insights-on-bone-disease-impact-of-flt201-in-adults-with-gaucher-disease-type-1 Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1 https://ml.globenewswire.com/media/195ccecc-f977-4fb5-ba01-43af7ec47589/small/spur-therapeutics-black-wopacity-rgb-png.png https://www.technologytimesnewjersey.com/article/910242445-zoom-recognizes-the-rise-of-ai-powered-businesses-of-one-with-inaugural-solopreneur-50 Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50 https://ml.globenewswire.com/media/1a5e6f52-9a8e-432b-84cc-7dfb0e6623e2/small/logo-zm-app-icon-container-png.png https://www.technologytimesnewjersey.com/article/910242449-kyverna-therapeutics-appoints-nadia-dac-seasoned-commercial-leader-in-neurology-and-rare-disease-as-chief-commercial-officer Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.technologytimesnewjersey.com/article/910242457-4dmt-to-participate-in-upcoming-investor-conferences Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 4DMT to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png https://www.technologytimesnewjersey.com/article/910242470-valitor-presents-preclinical-data-demonstrating-superior-durability-with-six-month-treatment-protocol-of-vltr-559-to-treat-wet-amd Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png https://www.technologytimesnewjersey.com/article/910242472-applied-digital-announces-300-million-senior-secured-bridge-facility Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Applied Digital Announces $300 Million Senior Secured Bridge Facility https://ml.globenewswire.com/media/a09f7f80-1e66-44ed-b53a-6007ec7be92a/small/applied-digital-logo-horizontal-black-png.png https://www.technologytimesnewjersey.com/article/910242494-tessell-appoints-matt-mcdonough-and-jeffrey-carter-to-executive-team-to-accelerate-enterprise-database-modernization Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Tessell Appoints Matt McDonough and Jeffrey Carter to Executive Team to Accelerate Enterprise Database Modernization https://ml.globenewswire.com/media/503f121a-0162-4ce3-84b3-ae5e04dc98e5/medium/jeff-carter-chief-strategy-officer.jpeg https://www.technologytimesnewjersey.com/article/910242516-kaltura-open-sources-suite-of-ai-agent-skills-enabling-any-ai-agent-to-build-intelligent-rich-media-digital-experiences Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Kaltura Open-Sources Suite of AI Agent Skills, Enabling Any AI Agent to Build Intelligent Rich-Media Digital Experiences https://ml.globenewswire.com/media/584e487b-dd12-4a20-a5b1-c42f4579d369/small/kaltura-logo-vertical-colorsun-blacktext-small.png https://www.technologytimesnewjersey.com/article/910242538-lifeward-announces-new-rewalk-data-presented-at-asia-2026-conference-demonstrating-a-comprehensive-longitudinal-safety-analysis-for-a-powered Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg https://www.technologytimesnewjersey.com/article/910242564-atsena-presents-positive-interim-six-month-results-from-part-b-of-phase-1-2-3-lighthouse-trial-evaluating-atsn-201-in-patients-with-x-linked Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910242567-rocket-doctor-ai-reports-strong-2025-results-validating-physician-led-model-with-key-u-s-payer-contracts-and-ai-innovation Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation https://ml.globenewswire.com/media/648c6dd6-c4c0-4ceb-9a78-26fecd4678a7/small/rocket-doctor-logo-250821-png.png https://www.technologytimesnewjersey.com/article/910242574-after-successful-fda-meeting-clene-filing-accelerated-approval-nda-for-als Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png https://www.technologytimesnewjersey.com/article/910242582-legend-biotech-expands-scientific-advisory-expertise-to-inform-future-growth Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png https://www.technologytimesnewjersey.com/article/910242595-swarmer-partners-with-rakuten-to-enter-japan-s-advanced-autonomy-market Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Swarmer Partners With Rakuten to Enter Japan's Advanced Autonomy Market https://ml.globenewswire.com/media/46b28796-9654-4d2b-89db-91de399ba76a/small/swarmer-logo-dark-png.png https://www.technologytimesnewjersey.com/article/910242608-ruanyun-edai-technology-s-saudi-rhq-signs-mou-with-wadi-makkah-a-subsidiary-of-umm-al-qura-university Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Ruanyun Edai Technology’s Saudi RHQ Signs MOU with Wadi Makkah, A Subsidiary of Umm Al-Qura University https://ml.globenewswire.com/media/0b7372f3-6354-4bba-acc5-bb10b1de4c3a/small/logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910237832-macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyz-royalty-purchase-agreement Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png https://www.technologytimesnewjersey.com/article/910237841-bridgebio-to-present-new-acoramidis-data-on-disease-progression-biomarkers-and-clinical-outcomes-at-esc-heart-failure-2026 Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026 https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.technologytimesnewjersey.com/article/910237849-kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.technologytimesnewjersey.com/article/910237860-palvella-therapeutics-announces-first-patients-dosed-in-phase-2-lotu-trial-of-fast-track-designated-qtorin-rapamycin-for-clinically-significant Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.technologytimesnewjersey.com/article/910237878-inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.technologytimesnewjersey.com/article/910237897-earthdaily-advancing-daily-global-measurement-of-planetary-change-with-six-satellites-launched Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 EarthDaily Advancing Daily Global Measurement of Planetary Change with Six Satellites Launched https://ml.globenewswire.com/media/63895f31-922c-451d-894e-110f2f640ad9/medium/earthdaily-satellite-deploys.png https://www.technologytimesnewjersey.com/article/910237911-windward-bio-announces-165m-crossover-financing-to-advance-pipeline-of-long-acting-immunology-therapies-with-best-in-disease-potential Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential https://ml.globenewswire.com/media/Nzk5NDkzNGQtNWZiNi00MGZkLTg2ZTAtYzViNDkwNTJjOTVmLTUwMDEzMTYxMS0yMDI2LTA1LTA0LWVu/tiny/Windward-Bio.png https://www.technologytimesnewjersey.com/article/910237925-micropolis-robotics-unveils-new-next-generation-high-endurance-robot-at-the-make-it-in-the-emirates-2026-industry-exhibition Technology Times New Jersey en PressRelease 2026-05-04T11:29:19+00:00 Micropolis Robotics Unveils New, Next-Generation, High-Endurance Robot at the Make it in the Emirates 2026 Industry Exhibition https://ml.globenewswire.com/media/ffdb8f0a-5da0-4cdc-9a97-852140e69d8b/medium/m1-5.JPG https://www.technologytimesnewjersey.com/article/910237843-cartesian-therapeutics-announces-new-employment-inducement-grants Technology Times New Jersey en PressRelease 2026-05-04T11:05:00+00:00 Cartesian Therapeutics Announces New Employment Inducement Grants https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png https://www.technologytimesnewjersey.com/article/910237845-nextcure-and-simcere-zaiming-initiate-dose-optimization-for-sim0505-cdh6-adc-in-gynecologic-cancers Technology Times New Jersey en PressRelease 2026-05-04T11:05:00+00:00 NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg https://www.technologytimesnewjersey.com/article/910237870-kraig-biocraft-laboratories-launches-april-may-production-cycle-following-record-spider-silk-output Technology Times New Jersey en PressRelease 2026-05-04T11:05:00+00:00 Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910233519-ardena-strengthens-executive-team-to-drive-its-next-phase-of-growth Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Ardena Strengthens Executive Team to Drive its Next Phase of Growth https://ml-eu.globenewswire.com/media/eddef504-18ee-4f10-8442-9e61ef77e262/medium/ardena-appoints-cfo-and-cco.png https://www.technologytimesnewjersey.com/article/910233520-indivior-announces-175-million-accelerated-share-repurchase Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Indivior Announces $175 Million Accelerated Share Repurchase https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910233589-advanced-technology-recycling-atr-announces-that-they-are-now-offering-wholesale-electronics-to-the-general-public-through-their-online-auction-site Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Advanced Technology Recycling (ATR) Announces That They Are Now Offering Wholesale Electronics to the General Public Through Their Online Auction Site https://ml.globenewswire.com/media/437d4f24-24b9-4cd4-961b-ea5dd0ab80ce/small/atr-logo-with-registered-trademark-badge-jpg.jpg https://www.technologytimesnewjersey.com/article/910233590-biocryst-announces-european-licensing-agreement-with-irish-affiliate-of-neopharmed-gentili-for-navenibart-in-hereditary-angioedema Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.technologytimesnewjersey.com/article/910233621-tenax-therapeutics-appoints-timothy-healey-mba-as-chief-commercial-officer Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg